SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 94 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,000 | -50.0% | 2,010 | -44.4% | 0.00% | – |
| Q1 2022 | $4,000 | -92.6% | 3,616 | -78.1% | 0.00% | – |
| Q4 2021 | $54,000 | +25.6% | 16,526 | +70.3% | 0.00% | – |
| Q3 2021 | $43,000 | +22.9% | 9,702 | +49.5% | 0.00% | – |
| Q2 2021 | $35,000 | +9.4% | 6,489 | +50.9% | 0.00% | – |
| Q1 2021 | $32,000 | -97.7% | 4,301 | -96.7% | 0.00% | -100.0% |
| Q4 2020 | $1,400,000 | +2313.8% | 129,003 | +1873.4% | 0.00% | – |
| Q3 2020 | $58,000 | -92.3% | 6,537 | -90.7% | 0.00% | -100.0% |
| Q2 2020 | $752,000 | +902.7% | 70,502 | +458.3% | 0.00% | – |
| Q1 2020 | $75,000 | +5.6% | 12,627 | +23.4% | 0.00% | – |
| Q4 2019 | $71,000 | +82.1% | 10,236 | +175.0% | 0.00% | – |
| Q3 2019 | $39,000 | -60.6% | 3,722 | -65.2% | 0.00% | – |
| Q2 2019 | $99,000 | +45.6% | 10,694 | +45.2% | 0.00% | – |
| Q1 2019 | $68,000 | +88.9% | 7,367 | +13.5% | 0.00% | – |
| Q4 2018 | $36,000 | -56.6% | 6,489 | -6.6% | 0.00% | – |
| Q3 2018 | $83,000 | +232.0% | 6,948 | +260.7% | 0.00% | – |
| Q1 2018 | $25,000 | +1150.0% | 1,926 | +867.8% | 0.00% | – |
| Q4 2017 | $2,000 | +100.0% | 199 | +139.8% | 0.00% | – |
| Q2 2017 | $1,000 | -50.0% | 83 | -33.1% | 0.00% | – |
| Q1 2017 | $2,000 | -60.0% | 124 | -67.5% | 0.00% | – |
| Q3 2016 | $5,000 | – | 381 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |